RxDoctor Payments Data

Barton Wild, MD

Interventional Pain Medicine · Portage, MINPI 1710197579

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.5% of the total across 355 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Abbott accounts for 82.5% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2021 at $1,730 and has fallen 88.2% since, to $204 in 2025.

$6,540in general payments, 2019–2025

Across 355 payments — averaging $18.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$5K
  • Nevro Corp.$184
  • Stryker$174
  • Boston Scientific$174
  • Si-bone, Inc.$131
  • Medtronic$108
  • plus $371 from 10 others

What the payments were for

  • Travel & lodging$1612%
  • Food & beverage$6,38098%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,540 in reported general payments places this provider in the 75th percentile of 88 interventional pain medicine providers in Michigan.

See all interventional pain medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$520,700
Medicare patients
558
Services billed
26,357

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen404$8,617
Fentanyl39$7,192
Gabapentin410$4,726
Morphine Sulfate ErMorphine Sulfate181$4,572
Pregabalin106$1,679
Tizanidine Hcl77$1,403
Diclofenac Sodium116$1,162
Naloxone Hcl17$1,145
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen38$917
Cyclobenzaprine Hcl88$793
Tramadol Hcl119$709
Baclofen73$660
Methadone Hcl39$596
Duloxetine Hcl26$408
Acetaminophen-CodeineAcetaminophen With Codeine28$302

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Portage

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →